A Study of Avutometinib and Defactinib in People With Thyroid Cancer
Clinical trial NCT06007924 · RECRUITING
Trial details
- NCT number
- NCT06007924
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-16
- Primary completion
- 2027-08-16
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.